DABIGATRAN ETEXILATE MESYLATE (DABIGATRAN ETEXILATE MESYLATE) — FDA Approval ANDA207922 (BRECKENRIDGE)
DABIGATRAN ETEXILATE MESYLATE (DABIGATRAN ETEXILATE MESYLATE) — FDA Approval ANDA207922 (BRECKENRIDGE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DABIGATRAN ETEXILATE MESYLATE; Active ingredients: DABIGATRAN ETEXILATE MESYLATE; Application number: ANDA207922.
| Brand name | DABIGATRAN ETEXILATE MESYLATE |
|---|---|
| Active ingredients | DABIGATRAN ETEXILATE MESYLATE |
| Application number | ANDA207922 |
| Sponsor | BRECKENRIDGE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20241219 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →